Coherus Oncology, Inc. — Director's Dealing 2015

Jan 2, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Coherus BioSciences, Inc. (CHRS)
CIK: 0001512762
Period of Report: 2014-12-31

Reporting Person: LAWLIS V BRYAN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-31	Stock Option (Right to Buy)	$16.32	A	15000	Acquired	2024-12-30	Common Stock (15000)	Direct

Footnotes

F1: The stock option vests pursuant to the following schedule: One Forty Eighth (1/48th) of the option vests and becomes exercisable in successive, equal monthly installments measured from June 30, 2014, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.